Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Meirik

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Acta Endocrinologica|November 1, 1987
The postpartum period constitutes an important risk for the development of clinical Graves' disease in young womenR Jansson, P A Dahlberg, B Winsa, et al.
Clinical Genetics|October 1, 1987
Relative effect of parental birth weight on infant birth weight at termJ Langhoff-Roos, G Lindmark, K H Gustavson, et al.
Cancer|August 15, 1985
Age as a prognostic factor in breast cancerH O Adami, B Malker, O Meirik, et al.
Lancet (London, England)|March 8, 1997
Third-generation oral contraceptives and venous thrombosisN R Poulter, C L Chang, M Marmot, et al.
Lancet (London, England)|September 20, 1986
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and NorwayO Meirik, E Lund, H O Adami, et al.
Lancet (London, England)|May 2, 1987
Oral contraceptives and breast cancerO Meirik, E Lund, H O Adami, et al.
Lancet (London, England)|November 29, 1986
Oral contraceptives and breast cancerO Meirik, E Lund, H O Adami, et al.
International Journal of Epidemiology|September 1, 1989
Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of useE Lund, O Meirik, H O Adami, et al.
Contraception|April 29, 1998
Oral contraceptives and risk of venous thromboembolism: impact of duration of useT M Farley, O Meirik, M G Marmot, et al.
Contraception|September 1, 1996
Oral contraceptives and thrombotic diseases: impact of new epidemiological studiesT M Farley, O Meirik, N R Poulter, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Acta Endocrinologica|November 1, 1987
The postpartum period constitutes an important risk for the development of clinical Graves' disease in young womenR Jansson, P A Dahlberg, B Winsa, et al.
Clinical Genetics|October 1, 1987
Relative effect of parental birth weight on infant birth weight at termJ Langhoff-Roos, G Lindmark, K H Gustavson, et al.
Cancer|August 15, 1985
Age as a prognostic factor in breast cancerH O Adami, B Malker, O Meirik, et al.
Lancet (London, England)|March 8, 1997
Third-generation oral contraceptives and venous thrombosisN R Poulter, C L Chang, M Marmot, et al.
Lancet (London, England)|September 20, 1986
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and NorwayO Meirik, E Lund, H O Adami, et al.
Lancet (London, England)|May 2, 1987
Oral contraceptives and breast cancerO Meirik, E Lund, H O Adami, et al.
Lancet (London, England)|November 29, 1986
Oral contraceptives and breast cancerO Meirik, E Lund, H O Adami, et al.
International Journal of Epidemiology|September 1, 1989
Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of useE Lund, O Meirik, H O Adami, et al.
Contraception|April 29, 1998
Oral contraceptives and risk of venous thromboembolism: impact of duration of useT M Farley, O Meirik, M G Marmot, et al.
Contraception|September 1, 1996
Oral contraceptives and thrombotic diseases: impact of new epidemiological studiesT M Farley, O Meirik, N R Poulter, et al.
Pageof 9